Executive Overview

In a precautionary measure reflecting the heightened scrutiny surrounding pet food and supplement safety, New York-based pet technology and wellness company Fi has initiated a nationwide voluntary recall of select lots of its canine nutritional supplements. The recall was prompted by notifications from a third-party ingredient supplier indicating that a raw material utilized in the manufacturing process may have been contaminated with Salmonella bacteria.

Upon receiving notice from the upstream supplier, the contract manufacturer responsible for producing Fi’s supplement line immediately suspended manufacturing operations. An investigative audit is currently underway to trace the origin of the batch contamination, evaluate quality assurance protocols, and prevent further distribution of potentially affected products.

+-----------------------------------------------------------------------------------+
|                               RECALL SUMMARY MATRIX                               |
+------------------------------------+------------+------------------+--------------+
| Product Description                | Net Weight | Lot Number       | UPC          |
+------------------------------------+------------+------------------+--------------+
| Fi Calming Supplement for Dogs     | 180 g      | 26118            | 850064800111 |
| Fi 8-in-1 Formula Supplement Dogs  | 180 g      | 26159            | 850055111684 |
+------------------------------------+------------+------------------+--------------+
| Distribution Channels: Direct-to-Consumer (D2C), Amazon.com, Chewy.com            |
+-----------------------------------------------------------------------------------+

The recall affects two distinct product formulations: the Fi Calming Supplement for Dogs (180 g) and the Fi 8-in-1 Formula Supplement for Dogs (180 g). These products were distributed across the United States directly through Fi’s e-commerce platform as well as major online retail marketplaces, including Amazon and Chewy.com.

While no confirmed human or animal illnesses have been definitively tied to the recalled lots to date, the U.S. Food and Drug Administration (FDA) and veterinary health authorities emphasize that Salmonella poses significant dual-pathway hazards. It presents a primary risk of infection to dogs ingesting the soft chews and a secondary cross-contamination risk to human owners who handle the products, touch exposed food bowls, or come into contact with waste from infected pets.

Detailed Chronology of the Incident

The events leading to the nationwide market withdrawal demonstrate how vulnerable modern pet wellness brands are to upstream supply chain disruptions.

       [ Upstream Ingredient Supplier ]
                     │  (Flags Potential Salmonella Contamination)
                     ▼
       [ Contract Manufacturing Partner ]
                     │  (Halts Production & Audits Batch Records)
                     ▼
       [ Fi Corporate HQ (New York, NY) ]
                     │  (Traces Lots: 26118 & 26159)
                     ▼
 [ FDA Center for Veterinary Medicine ] <───> [ Multi-Channel Recall Action ]
  (Public Safety Alert & Form 1932a)           • Direct-to-Consumer (D2C)
                                               • Amazon.com Delisting
                                               • Chewy.com Inventory Purge

Phase 1: Upstream Detection and Manufacturing Halt

The safety issue originated at the raw material level. A third-party supplier that provides bulk active ingredients and botanical extracts to Fi’s contract manufacturer identified potential microbial contamination during routine post-production testing. Following standard risk-mitigation protocols, the supplier notified the contract manufacturer, which immediately froze all ongoing production runs associated with the affected ingredient batch.

Phase 2: Internal Traceability and Inventory Isolation

Upon receiving notice from the contract manufacturer, Fi’s quality assurance team launched an immediate traceability analysis to isolate all finished product batches that contained the affected ingredient. The inventory audit identified two specific production runs—Lot 26118 (Calming Supplement) and Lot 26159 (8-in-1 Formula)—that had already passed initial quality checks and entered commercial fulfillment networks.

Phase 3: Regulatory Notification and Channel Delisting

Acting "out of an abundance of caution," Fi formally alerted the FDA’s Center for Veterinary Medicine (CVM) and initiated a voluntary recall protocol under federal guidelines. Simultaneously, Fi communicated with its primary digital retail partners, Amazon and Chewy.com, requesting the immediate removal of the affected product lots from their active distribution centers and online storefronts.

Phase 4: Direct-to-Consumer Outreach and Public Alert

To contain consumer exposure, Fi began directly contacting registered retail buyers who purchased the recalled lots via direct email and customer portal alerts. The public notice was subsequently published on the FDA’s Recall, Market Withdrawals, & Safety Alerts portal, advising all pet owners to inspect their supplement containers and immediately discontinue use if their lot numbers match the recalled batches.

Supporting Context & Industry Metrics

The Microbiology of Salmonella and Zoonotic Exposure

Salmonella is a genus of rod-shaped, Gram-negative enterobacteria that remains one of the primary causes of foodborne illness worldwide. In pet care, Salmonella contamination presents a complex public health challenge due to its zoonotic potential—meaning the pathogen can readily jump between animals and humans through both direct and indirect vectors.

                  [ Pathogen Transmission Pathways ]

   +-------------------+                     +-------------------+
   | Recalled Soft     | ── Ingestion ────>  | Canine Companion  |
   | Supplement Chews  |                     | (Active/Carrier)  |
   +-------------------+                     +-------------------+
             │                                         │
             │ Handling                                │ Fecal Excretion
             ▼                                         ▼
   +-------------------+                     +-------------------+
   | Human Caregiver   | <── Cross-Contam. ─ | Feces / Surfaces  |
   | (Hand-to-Mouth)   |                     | / Dog Bowls       |
   +-------------------+                     +-------------------+

Dogs ingesting Salmonella-contaminated chews can experience localized gastrointestinal distress or systemic disease. Crucially, canines can also become asymptomatic carriers. An infected dog may show no outward signs of illness yet shed Salmonella bacteria in its feces and saliva for weeks. This poses an unseen risk to household members—particularly young children, the elderly, pregnant women, and immunocompromised individuals—who can contract salmonellosis by handling the pet, cleaning waste, or touching contaminated surfaces followed by hand-to-mouth contact.

The Dynamics of the Pet Supplement Market

The recall highlights the rapid growth and inherent supply chain complexities of the premium pet wellness sector. According to industry market research, the global pet supplement market has expanded significantly, driven by the "humanization" of pets, with owners increasingly purchasing functional chews for anxiety relief, joint health, and gut wellness.

Because many digital-first pet brands utilize third-party CMOs to blend active ingredients, compress soft chews, and package finished goods, a single contaminated raw material at an upstream ingredient supplier can quickly compromise finished goods across multiple brands and retail networks.

Official Statements and Clinical Symptomatology

Public Health Guidelines for Human Handling

Public health officials stress that individuals who have handled the recalled Fi supplements should monitor their health closely. Symptoms of human salmonellosis typically manifest within 12 to 72 hours after exposure and include:

• Common Clinical Symptoms: Nausea, persistent vomiting, severe abdominal cramps, watery diarrhea, bloody diarrhea, and sudden onset of fever.
• Rare & Severe Complications: In high-risk individuals, Salmonella can penetrate the intestinal lining and enter the bloodstream, leading to severe systemic ailments such as arterial infections (infected aneurysms), endocarditis (infection of the heart valves), reactive arthritis, diffuse muscle pain, eye irritation (conjunctivitis), and urinary tract symptoms.

Consumers experiencing any of these symptoms after handling the affected supplements are advised to seek medical attention immediately and inform their healthcare provider of potential Salmonella exposure.

Clinical Manifestations in Canine Patients

Veterinarians advise pet owners to conduct a thorough physical check of dogs that have ingested products from Lot 26118 or Lot 26159. Clinical signs in canines may vary based on age, breed, and baseline immune health:

+-----------------------------------------------------------------------------------+
|                        CANINE SALMONELLOSIS SYMPTOM PROFILE                       |
+------------------------------------+----------------------------------------------+
| Mild to Moderate Symptoms          | Severe / Systemic Indications                |
+------------------------------------+----------------------------------------------+
| • Sudden Lethargy / Depression     | • High Fever & Severe Dehydration            |
| • Decreased Appetite (Anorexia)    | • Profuse Bloody Diarrhea (Dysentery)        |
| • Abdominal Pain / Sensitivity     | • Persistent Retching and Vomiting           |
| • Acute Mucous or Watery Diarrhea  | • Asymptomatic Carrier State (Fecal Shedding)|
+------------------------------------+----------------------------------------------+

If a dog exhibits any of these symptoms after consuming the recalled supplement, pet parents should isolate the animal from other pets and family members and contact a licensed veterinarian immediately.

Official Directives & Contact Channels

Fi has instructed all customers in possession of the recalled lots to immediately cease feeding the product to their dogs. The company has released explicit disposal and contact guidelines:

1. Disposal Protocol: Do not donate, resell, or feed the product to wildlife. Ensure the container lid is tightly sealed to prevent secondary access by children or pets, double-bag the container, and dispose of it directly into an outdoor household trash receptacle. Thoroughly wash and sanitize all kitchen counters, pet bowls, and storage areas that came into contact with the container.
2. Fi Customer Support: Consumers seeking refunds, product replacements, or further details regarding the recall can contact Fi’s support team through the following channels:
   • Toll-Free Phone: 1-888-434-3647 (Available 7 days a week, from 10:00 AM to 8:00 PM Eastern Time).
   • Email Support: [email protected]
3. FDA Adverse Event Reporting: Both consumers and veterinary practitioners who suspect adverse health events related to these products are encouraged to submit a formal report to the FDA CVM Adverse Event Reporting program by completing the online Form FDA 1932a, accessible via the official portal at www.fda.gov/reportanimalae.

Future Outlook & Industry Implications

Supply Chain Auditability and Quality Control Trends

This incident underscores the critical necessity for strict supply chain auditing throughout the pet wellness sector. As digital native pet brands scale up their product offerings beyond smart hardware into functional nutrition, establishing rigorous quality control frameworks becomes paramount.

Moving forward, industry analysts expect increased pressure on brands to implement hazard analysis and critical control point (HACCP) protocols alongside aggressive test-and-hold procedures for every raw material lot entering manufacturing facilities. Contracting third-party laboratories to run independent, double-blind microbial screening for pathogens like Salmonella, Listeria monocytogenes, and E. coli prior to final product distribution will likely become standard operating practice.

       [ Upstream Raw Material Testing ]
                     │
                     ▼
       [ Contract Manufacturer HACCP Audit ]
                     │
                     ▼
       [ Independent Laboratory Validation ]
                     │
                     ▼
       [ "Test-and-Hold" Lot Verification ]
                     │
                     ▼
       [ Safe Release to D2C & Retail Markets ]

Regulatory Landscape Under FSMA

The FDA’s Center for Veterinary Medicine continues to heighten enforcement of the Food Safety Modernization Act (FSMA) rules for animal food and supplement facilities. Manufacturers face rigorous inspections concerning sanitation controls, preventive controls for animal food, and supply-chain oversight programs.

For Fi, resolving this recall successfully will require working closely with its contract manufacturing partner to identify the precise breakdown in the raw material supply chain. Once the root cause is established and corrective and preventive action (CAPA) plans are submitted to the FDA, production for the affected supplement lines is expected to resume under enhanced screening protocols.

Guidance for Pet Owners Navigating Supplement Recalls

As nutritional supplements remain a popular tool for preventive canine health care, pet owners are encouraged to remain proactive regarding product safety:

• Check Lot Numbers Regularly: Always inspect outer packaging for lot codes, expiration dates, and manufacturer contact details upon receipt.
• Maintain Digital Purchase Records: Retain order confirmations from e-commerce platforms like Chewy and Amazon to simplify lot tracking during voluntary recall actions.
• Practice Safe Handling Practices: Treat pet functional chews with the same hygiene standards applied to human food—wash hands thoroughly with warm water and soap for at least 20 seconds after handling pet chews and store supplements in cool, dry areas away from food preparation zones.

By adhering to these precautionary measures, pet parents can help protect both their household members and their dogs from foodborne pathogens while the industry continues working toward safer, more transparent supply chains.